Quantbot Technologies’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-16,828
Closed -$1.35M 1893
2025
Q4
$1.35M Buy
+16,828
New +$1.13M 0.04% 573
2025
Q1
Sell
-4,415
Closed -$345K 1638
2024
Q4
$345K Buy
+4,415
New +$355K 0.01% 926
2024
Q2
Sell
-14,068
Closed -$1.2M 1625
2024
Q1
$1.2M Buy
14,068
+13,429
+2,102% +$1.05M 0.07% 436
2023
Q4
$54.6K Buy
+639
New +$55.2K ﹤0.01% 1317
2023
Q3
Sell
-1,779
Closed -$151K 1714
2023
Q2
$151K Buy
+1,779
New +$150K 0.01% 1061
2023
Q1
Sell
-1,075
Closed -$84.5K 1752
2022
Q4
$84.5K Buy
+1,075
New +$86.4K 0.01% 1186
2022
Q1
Sell
-32,535
Closed -$1.73M 1803
2021
Q4
$1.73M Buy
+32,535
New +$1.98M 0.14% 214
2021
Q2
Sell
-4,764
Closed -$528K 1607
2021
Q1
$528K Buy
+4,764
New +$590K 0.05% 475
2020
Q1
Sell
-19,676
Closed -$2.26M 1088
2019
Q4
$2.26M Buy
+19,676
New +$2.38M 0.22% 129
2019
Q2
Sell
-9,875
Closed -$863K 1288
2019
Q1
$863K Buy
9,875
+7,829
+383% +$712K 0.08% 308
2018
Q4
$204K Buy
2,046
+1,667
+440% +$175K 0.02% 639
2018
Q3
$43K Sell
379
-20,996
-98% -$2.17M ﹤0.01% 1065
2018
Q2
$1.92M Buy
+21,375
New +$1.81M 0.13% 236
2015
Q4
Sell
-5,181
Closed -$167K 1192
2015
Q3
$167K Buy
+5,181
New +$195K 0.03% 586
2015
Q2
Sell
-133
Closed -$5K 1213
2015
Q1
$5K Buy
+133
New +$5.56K ﹤0.01% 989
2014
Q2
Sell
-6,000
Closed -$195K 1253
2014
Q1
$195K Buy
6,000
+5,900
+5,900% +$225K 0.05% 447
2013
Q4
$4K Buy
+100
New +$4.12K ﹤0.01% 929

Other funds holding HAE

Quantbot Technologies's HAE Position: Q1 2026 in Review

Quantbot Technologies sold out of Haemonetics (HAE) in Q1 2026, closing a stake of 16,828 shares — an estimated $1.35M sold.

Quantbot Technologies first reported a position in HAE in Q4 2013 and held it in 17 quarters. The position peaked at $2.26M in Q4 2019. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • Quantbot Technologies reported no remaining Haemonetics position as of Q1 2026 after selling out during the quarter.
  • Quantbot Technologies sold 16,828 Haemonetics shares in Q1 2026, an estimated $1.35M.
  • Quantbot Technologies first reported a position in Haemonetics in Q4 2013 and held it in 17 quarters.
  • Quantbot Technologies's Haemonetics position peaked at $2.26M in Q4 2019.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.